Fitch Places Thermo Fisher, Life Tech Ratings on Negative Watch after Announcement of $13.6B Deal | GenomeWeb

NEW YORK (GenomeWeb News) – Fitch Ratings placed the ratings of Thermo Fisher Scientific and Life Technologies on Rating Watch Negative following Thermo Fisher's announcement on Monday that it plans to buy Life Tech for $13.6 million.

Thermo Fisher's ratings that were placed on Rating Watch Negative include the company's long-term issuer default rating, which is rated BBB+; short-term IDR, rated F2; senior notes, rated BBB+; and commercial paper, rated F2.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.

Apr
13
Sponsored by
SeraCare

In this webinar, Gregory J. Tsongalis of Dartmouth Hitchcock Medical Center will discuss how his lab developed and validated a cancer hotspot assay. 

Apr
27
Sponsored by
SeraCare

This webinar is the third in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.

May
09
Sponsored by
SeraCare

This webinar is the last in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.